Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Researchers developed a method to detect hormone-blocking drugs in wastewater and found them in Beijing's sewage, suggesting they can survive sewage treatment.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Menopause affects hair and skin; more research needed for treatment.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Laser hair removal is effective for dark hair but needs improvement for nonpigmented or fine hairs.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Menopause can cause skin issues, and seeing a dermatologist helps.

Blocking interferon-gamma might help treat various autoimmune diseases.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

Women with PCOS who have high male hormone levels often also have insulin resistance.

Hormonal treatments like birth control pills can improve acne in women with excess hair growth and hormone imbalances.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.

A new platinum complex was made and studied, which might help fight cancer better.

A girl with Denys-Drash syndrome was misdiagnosed due to biotin affecting her hormone test results.